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Background: Estimated continuous cardiac output（esCCO）is a non-invasive technique for 
monitoring continuous cardiac output（CCO）that is based on pulse-wave transit time. In this 
study, we report the use of CCO monitoring for patients undergoing robot-assisted surgery with 
pneumoperitoneum in a head-down position.
Method: Thirteen patients undergoing radical robot-assisted prostatectomy under general anesthesia 
were enrolled. Intraoperatively, esCCO and arterial pressure-based cardiac output（APCO）were 
simultaneously recorded. The association between esCCO and APCO was then evaluated using 
correlation analysis and Bland-Altman analysis. The trending ability of esCCO was evaluated by 
4-quadrant plot analysis.
Results: The correlation coefficient between esCCO and APCO was 0.54（P < 0.0001）. According 
to the Bland-Altman plot, the bias and precision values were 1.38 and 0.79 L/min, respectively. The 
concordance analysis showed the concordance rate of 92.3%.
Conclusion: These results indicate that esCCO is capable of tracking hemodynamic changes 
associated with pneumoperitoneum in the head-down position.
Keywords: continuous cardiac output, head-down position, pnuemoperitoneum
Introduction
Tissue hypoperfusion is an important factor 
associated with postoperative complications１），２）．
Both perioperative dehydration and presence of 
excess fluid can increase postoperative complications, 
leading to longer hospital stays and increased 
hospitalization costs３）．Goal-directed therapy using 
infusion control and inotropic drug administration has 
reduced the time required for gastrointestinal tract 
function recovery after surgery４）．Thus, appropriate 
management of hemodynamics is required during 
the perioperative period, for which various minimally 
invasive hemodynamic monitors have been developed 
recently.
Estimated continuous cardiac output（esCCO）
is a non-invasive method for continuous cardiac 
output（CO）measurement５），６）．Based on pulse 
wave transit time technology, esCCO measures 
continuous cardiac output（CCO）noninvasively 
using electrocardiogram（ECG）, pulse oximetry, 
noninvasive blood pressure monitoring, and patient 
demographic information. Several studies have 
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shown its usefulness in abdominal surgery, thoracic 
surgery, and the intensive care setting７），８）．
Pneumoperitoneum and the head-down position 
affects hemodynamics９）, but there has been no 
reports of using esCCO under these conditions. In 
this study, we used esCCO in the head-down position 
and laparoscopic surgery and compared esCCO with 
arterial pressure-based cardiac output（APCO）.
Materials and Methods
Patients
In the present study, 13 patients with American 
Soc ie ty  o f  Anesthes io l ogy phys ica l  s ta tus 
classification 1-2 undergoing radical robot-assisted 
prostatectomy under general anesthesia at Yamagata 
University Hospital（Yamagata, Japan）from 
November 2015 to February 2016 were enrolled. 
Patients were excluded if they were diagnosed with 
marked cardiac arrhythmias. The study protocol 
and informed consent form were approved by the 
institutional review board of Yamagata University 
Hospital（No. 354）. All patients provided written 
informed consent to participate in this study.
Anesthesia and surgery
All patients were cannulated via the radial 
artery with a 22G catheter to monitor arterial 
blood pressure. Anesthesia was induced with target 
controlled infusion （TCI）3 ㎍/ml of propofol, 0.3 ㎍
/kg/min of remifentanil, and 0.6 mg/kg rocuronium 
bromide. Ventilation was controlled to maintain 
normocapnia with a tidal volume of 8 ml/kg（ideal 
body weight）with 40% oxygen in air. In addition, 
5 cmH2O positive end-expiratory pressure was 
applied. Propofol and remifentanil doses were 
adjusted so that the mean blood pressure was 
65 mmHg or more, and the bispectral index value 
was 40-60. Rocuronium bromide was continuously 
administered until the end of abdominal insufflation, 
and a muscle relaxation monitor confirmed that 
sufficient muscle relaxation was obtained. The head-
down position was set at 26 degrees with an angle 
gauge, and pneumoperitoneum pressure was set at 
12-15 mmHg.
Monitor
We connected the esCCO system to a pulse 
oximeter and an ECG unit and obtained esCCO. 
ECG and pulse oximetry wave data, as well as pulse 
wave transit time, were obtained using a BSM-9101 
bedside monitor（Nihon Kohden, Tokyo, Japan）
and transmitted to a personal computer with a 
c-compiled program for esCCO calculation. APCO 
was measured using FloTrac-Sensor software V4 
（Edwards Lifesciences, Irvine, CA）. The esCCO 
was calibrated before induction of anesthesia using 
ECG, pulse oximetry, non-invasive brachial blood 
pressure monitoring, and patient information（age, 
sex, height, and weight）. After induction of general 
anesthesia, esCCO and APCO were measured 
simultaneously.
Statistical analysis
Data are presented as mean±standard deviation 
（SD）. Correlation analysis and Bland-Altman 
analysis were performed to examine correlations 
between esCCO and APCO. A 4-quadrant plot 
analysis of ⊿APCO and ⊿esCCO was performed to 
evaluate the trending ability of esCCO. Values for 
⊿APCO and ⊿esCCO were calculated from the 
start of the events（head-down, pneumoperitoneum, 
head-down + pneumoperitoneum, pressure change, 
supine position, and medication administration
［ephedrine, phenylephrine, nicardipine］）, and after 
10 min. We excluded the central zone data of the 
4-quadrant plot with ⊿CO < 0.6 L/min. Based on the 
4-quadrant plot analysis, the concordance rate of two 
methods was calculated. Statistical significance was 
set at a P value（P）< 0.05. 
Statistical analyses were performed using 
Microsoft Excel 2013（Microsoft Corporation One 
Microsoft Way Redmond, WA 98052-7329 USA）and 
IBM SPSS Statistics 20.0.0（SPSS Inc., Chicago, IL, 
USA）software programs.
Result
Patient demographics are shown in Table1. 
Results of correlation analysis and Bland-Altman 
analysis are presented in Figure 1. The difference 
between esCCO and APCO was 1.38±0.79 L/min 
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with a linear correlation between two（r = 0.54, 
n = 10024, P < 0.0001）. The percentage error was 
63%. A 4-quadrant plot is presented in Figure 2. The 
concordance analysis showed a concordance rate of 
92.3%. 
Discussion
We used esCCO in operative patients during 
pneumoperitoneum in the head-down position 
and compared the results obtained with those of 
APCO. We used APCO as a reference monitor. 
APCO is commonly used for measuring CO values 
during the perioperative period and uses arterial 
pressure waveform analysis to calculate CO. A 
previous study found clinically acceptable agreement 
between APCO and pulmonary artery catheter 
standard bolus thermodilution（PAC）10）. Moreover, 
comparison of APCO and esCCO at the same time 
with intermittent bolus thermodilution CO in kidney 
transplant patients showed that the trending ability 
of esCCO is comparable with APCO11）. Because 
PAC was too invasive for patients in this study, 
we chose APCO as a reference monitor. If esCCO 
could capture changes in cardiac output during 
pneumoperitoneum in the head-down position as well 
as APCO, we considered it could be used clinically.
The value measured by esCCO tended to be 
Table 1． Patients demographicsTable .1 Patients demographics 
Age (years) 63.6±5.8 
Height (cm) 166.5±7.2 
Weight (kg) 64.7±10.8  
BMI (kg/m2) 23.2±2.6 
BSA (m2) 1.72±0.17 
Sex Male 13 
 
Values are presented as mean±standard deviation or n. 
BMI, body mass index; BSA, body surface area. 
 
Figure.1 
 
 
 
 
 
 
 
Table .1 Patients demographics 
Age (years) 63.6±5.8 
Height (cm) 166.5±7.2 
Weight (kg) 64.7±10.8  
BMI (kg/m2) 23.2±2.6 
BSA (m2) 1.72±0.17 
Sex Male 13 
 
Values are presented as mean±standard deviation or n. 
BMI, body mass index; BSA, body surface area. 
 
Figure.1 
 
 
 
 
 
 
 
Table .1 Patients demographics 
Age (years) 63.6±5.8 
Height (cm) 166.5±7.2 
Weight (kg) 64.7±10.8  
BMI (kg/m2) 23.2±2.6 
BSA (m2) 1.72±0.17 
Sex Male 13 
 
Values are presented as mean±standard deviation or n. 
BMI, body mass index; BSA, body surface area. 
 
Figure.1 
 
 
 
 
 
 
 
Table .1 Patients demographics 
Age (years) 63.6±5.8 
Height (cm) 166.5±7.2 
Weight (kg) 64.7±10.8  
BMI (kg/m2) 23.2±2.6 
BSA (m2) 1.72±0.17 
Sex Male 13 
 
Values are presented as mean±standard deviation or n. 
BMI, body mass index; BSA, body surface area. 
 
Figure.1 
 
 
 
 
 
 
 
Figure 1． Correlation between arterial pressure cardiac output (APCO) and estimated
 continuous cardiac output (esCCO; left), and Bland-Altman plot (right).
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Figure 2． A 4-quadrant plot of ⊿APCO and ⊿esCCO.
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higher than that by APCO. The Bland-Altman 
results show that the compatibility of esCCO 
and APCO was not very good. A previous study 
reported that the reliability of APCO decreases 
when the systemic vascular resistance index（SVRI）
is < 1200 or ≥ 250012）．In contrast, esCCO may be 
relatively accurate even in the presence of changes 
in systemic vascular resistance13），14）．The SVRI 
when measuring esCCO and APCO in one case in 
this study is presented in Figure 3. In patients with 
pneumoperitoneum, the SVRI is high; therefore; the 
reliability of the APCO value may be low, resulting 
in an increased difference between esCCO and 
APCO values.
The trending ability of esCCO at each event was 
acceptable. We evaluated the change 10 min after 
the event. The time interval at which changes should 
be measured was based on a prior study of fluid 
responsiveness15）．We set exclusion zones at 0.6 L/
min. According to Peyton et al.16），a concordance 
rate of 90% to 95% shows reliable trending ability 
for 0.5 to 1.0 L/min, or a 15% change. Our finding of 
92.3% concordance in this study indicates that the 
data is reliable. In situations resulting in a change in 
hemodynamics, it is important to follow the trend. 
Our experience suggests that esCCO can track 
hemodynamic changes as well as APCO.
In our study, the participants were all men and 
the sample size was small. Radical robot-assisted 
prostatectomy surgery was performed at a constant 
head low angle, and the operation time and blood loss 
were almost constant. In order to limit variability, we 
selectively enrolled patients undergoing radical robot-
assisted prostatectomy surgery. Therefore, further 
research may be needed to validate the trending 
ability of esCCO in patients of varying demographics 
and in different surgical situations. 
The results of this study were presented at the 
Japan Association for Clinical Monitoring Congress 
in 2016.
Conclusion
We evaluated esCCO in head-down position and 
laparoscopic surgery. We find that esCCO was able 
to track hemodynamic changes associated with 
pneumoperitoneum and in the head-down position.
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 Figure 3． Trend graph of estimated continuous cardiac output (esCCO, orange line),
 arterial pressure cardiac output (APCO, blue line), and systemic vascular
 resistance index (SVRI, purple line) in one case.
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